Quarterly report pursuant to Section 13 or 15(d)

Share-Based Compensation (Details 1)

v3.7.0.1
Share-Based Compensation (Details 1) - USD ($)
$ / shares in Units, $ in Thousands
 9 Months Ended 12 Months Ended
Mar. 31, 2017
Jun. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock Options, Outstanding at beginning of the period 12,273,334  
Stock Options, Granted 150,000  
Stock Options, Forfeited (116,665)  
Stock Options, Outstanding at end of the period 12,306,669 12,273,334
Stock Options, Vested and, as of March 31, 2017, expected to vest 12,276,498  
Stock Options, Exercisable as of March 31, 2017 9,478,362  
Weighted-average Exercise Price, Outstanding at beginning of the period $ 1.31  
Weighted-average Exercise Price, Granted 0.40  
Weighted-average Exercise Price, Forfeited 1.54  
Weighted-average Exercise Price, Outstanding at end of the period 1.30 $ 1.31
Weighted-average Exercise Price, Vested and, as of March 31, 2017, expected to vest 1.30  
Weighted-average Exercise Price, Exercisable as of March 31, 2017 $ 1.30  
Weighted-average Remaining Contractual Term (in years), Outstanding 5 years 7 months 6 days 6 years 4 months 24 days
Weighted-average Remaining Contractual Term (in years), Vested and, as of March 31, 2017, expected to vest 5 years 7 months 6 days  
Weighted-average Remaining Contractual Term (in years), Exercisable as of March 31, 2017 4 years 9 months 18 days  
Aggregate Intrinsic Value ,Outstanding $ 196 $ 993
Aggregate Intrinsic Value, Vested and, as of March 31, 2017, expected to vest 196  
Aggregate Intrinsic Value, Exercisable as of March 31, 2017 $ 191